Literature DB >> 1083559

Heterogeneity of B cells: direct evidence of selective triggering of distinct subpopulations by polyclonal activators.

E Gronowicz, A Coutinho.   

Abstract

This investigation was undertaken to assess directly the previous postulate that distinct subsets of B cells in the adult mouse spleen are selectivity triggered by different polyclonal B-cell activators (PBA). Several strains of mice and lipopolysaccharide (LPS), purified protein derivative of tuberculin (PPD), and dextran sulphate (DS) were used in this study. Two experimental approaches were used: stimulation after addition of two PBAs simultaneously to cell cultures and eliminating the responding population to one PBA, by a hot pulse of radioactive thymidine, on a later response to another PBA. The results of these experiments indicated that DS stimulated a cell population completely different from that stimulated by the LPS- and PPD-sensitive cells. When LPS and PPD stimulations were compared, it was found that the cells responding to these PBAs were largely distinct, although some cells were sensitive to both these PBAs. The extension of the overlaps in these subsets (the number of cells that could be activated by either PBA) was found to vary from one strain to another. These experiments gave direct evidence of the existence of subsets that can be activated by different PBAs. The present results also provided indications of the functional performance of distinct subsets of B cells on activation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083559     DOI: 10.1111/j.1365-3083.1976.tb02992.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  18 in total

1.  Nonspecific stimulation of lymphocytes by tuberculin.

Authors:  B M Sultzer; B S Nilsson; D Kirschenbaum
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

2.  Heteroantisera prepared against B lymphocytes at different stages of differentiation. II. Functional analysis of cytotoxicity to different B-cell populations.

Authors:  R M Gorczynski
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

Review 3.  The polyclonal expression of immunoglobulin variable region determinants on the membrane of B cells and their precursors.

Authors:  A Coutinho; L Forni; R R Bernabé
Journal:  Springer Semin Immunopathol       Date:  1980-08

4.  Heteroantisera prepared against B lymphocytes at different stages of differentiation. I. Preparation of sera and cytotoxicity to lymphoid cells from different organs.

Authors:  R M Gorczynski
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

5.  Polyclonal B-cell activation induced by extracts of Gram-negative bacteria isolated from periodontally diseased sites.

Authors:  P H Bick; A B Carpenter; L V Holdeman; G A Miller; R R Ranney; K G Palcanis; J G Tew
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

6.  Mild alkaline hydrolysis of lipopolysaccharide endotoxin enhances its mitogencity for murine B cells.

Authors:  G W Goodman; B M Sultzer
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

7.  Human peripheral blood lymphocyte activation by protein A from Staphylococcus aureus.

Authors:  W Y Chen; S Sager; E Tung; H H Fudenberg
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

8.  Nonspecific induction of immunoglobulin M antibodies to periodontal disease-associated microorganisms after polyclonal human B-lymphocyte activation by Fusobacterium nucleatum.

Authors:  D F Mangan; T Won; D E Lopatin
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Mitogenic activity of water-soluble adjuvant obtained from Bacterionema matruchotii.

Authors:  T Nitta; S Okumura; M Nakano
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

10.  In vitro expression of immunoglobulin M and G subclasses by murine B lymphocytes in response to a polyclonal activator from Actinomyces.

Authors:  J Clagett; D Engel; E Chi
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.